Neuralstem secures patent for stem cell transplantation

09/9/2009 | American City Business Journals

Neuralstem has received a patent for the production and transplantation of neural stem cells for the treatment of nervous system disorders. The company is awaiting a decision from the FDA on its request to start human trials of its stem cell therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY